Capricor Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of CAPR for the last quarter is 12.09 M USD, and it's 95.42% higher compared to the previous quarter. The net income of Q4 23 is -762.09 k USD.